StockWatch
·
Pharmaceuticals
Shareholding17 Nov 2026, 04:29 pm

Ghanshyam Jaju Converts 60,000 Warrants to Shares

AI Summary

Ghanshyam Jaju, Director of Godavari Drugs Limited, has disclosed the conversion of 60,000 convertible warrants into 60,000 equity shares. This transaction resulted in a change in his shareholding. Before the conversion, his total holding was 120,000 shares (0.96% of total capital) and 530,000 warrants (3.76% of total capital), totaling 4.24% of diluted capital. After the conversion, his shareholding increased to 470,000 shares, while his warrant holding decreased to 60,000 (0.48% of total capital). The total transaction involved 60,000 equity shares, representing a 0.51% change in voting rights and a 0.48% change in diluted capital. The conversion was an allotment of equity shares upon conversion of warrants on November 17, 2026.

Key Highlights

  • Ghanshyam Jaju converted 60,000 warrants into equity shares.
  • His shareholding increased by 60,000 shares.
  • The transaction represents a 0.51% change in voting rights.
  • The conversion impacts diluted shareholding by 0.48%.